Professor Carrier submitted a comment to the International Trade Commission in “In the Matter of Certain Video Capable Electronic Devices…” supporting the position of Amazon in a case brought by Nokia. Professor Carrier highlighted the importance of promises that patentholders make to reasonably license patents and how they should affect exclusion orders.
Author: Michael Carrier
Prof. Carrier’s work cited in Forbes and two FTC comments
Forbes article on product hopping https://www.forbes.com/sites/theapothecary/2024/05/21/how-drug-companies-stifle-competition-with-product-hopping/ FTC comment to Patent Office https://www.ftc.gov/system/files/ftc_gov/pdf/FTC-Comment-on-USPTO-Terminal-Disclaimer-NPRM-7-9-2024.pdf Statement of Commissioner Slaughter https://www.ftc.gov/system/files/ftc_gov/pdf/2410004exxonrksstmt_0.pdf
Prof. Carrier publishes articles on Ticketmaster, NCAA, & patent thickets
Michael A. Carrier, The Antitrust Case Against Live Nation Entertainment, 15 Harvard Journal of Sports and Entertainment Law 1 (2024), https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4657361 Michael A. Carrier & Marc Edelman, An Antitrust Analysis of the NCAA Transfer Policy, 11 Texas A&M Law Review 999 (2024), https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4636414 Michael A. Carrier & S. Sean Tu, Why Pharmaceutical Patent Thickets Are … Continue reading Prof. Carrier publishes articles on Ticketmaster, NCAA, & patent thickets…
Karyn Temple Presents 2024 Lastowka Lecture
On March 21, 2024, Karyn A. Temple, Senior Executive Vice President and Global General Counsel for the Motion Picture Association, presented the 2024 Lastowka lecture. Title “Chicken Little Was Wrong: A Site-Blocking Retrospective and Roadmap for the Future,” Ms. Temple explained the importance of measures like blocking piracy websites for targeting illegal infringement.
Prof. Carrier co-authors article on pharmaceutical patent thickets
Prof. Carrier co-authored an article, “Why Pharmaceutical Patent Thickets Are Unique,” with Sean Tu. The article explains the unique harms presented by patent thickets in the pharmaceutical industry… https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4571486